Efficacy and Safety of Lidocaine and Tetracaine Cream for Facial Laser Aesthetics in Chinese Adults

PHASE3CompletedINTERVENTIONAL
Enrollment

286

Participants

Timeline

Start Date

April 6, 2023

Primary Completion Date

August 23, 2023

Study Completion Date

October 25, 2023

Conditions
Analgesia
Interventions
DRUG

Lidocaine tetracaine cream

The test drug and the control drug will be uniformly spread over the treatment area using a tongue platula to form a thin layer of approximately 1 mm,right then left . The drug remained in the treatment area for 30 minutes (± 2 minutes) .

Trial Locations (11)

200011

Shanghai Ninth People Hospital,Shanghai Jiaotong University School of Medicine, Shanghai

Unknown

Beijing Hospital, Beijing

Beijing Tsinghua Changgung Hospital, Beijing

Peking University Shougang Hospital, Beijing

Xiangya Hospital Central South University, Changsha

West China School of Medicine West China Hospital of sichuan university, Chendu

Fujian Medical University Union Hospital, Fuzhou

Nanfang Hospital/Guangzhou, Guangzhou

Jiangsu Province Hospital, Nanjing

Union Hospital, Tongji Medical college huazhong university of science and technology, Wuhan

The affiliated hospital of xuzhou medical university, Xuzhou

All Listed Sponsors
lead

Cutia Therapeutics(Wuxi)Co.,Ltd

INDUSTRY

NCT05793892 - Efficacy and Safety of Lidocaine and Tetracaine Cream for Facial Laser Aesthetics in Chinese Adults | Biotech Hunter | Biotech Hunter